← All organizations
Gyeongsang University
Academic/HospitalWebsite ↗
Also known as: Changwon Gyeongsang National University Hospital | Gyeong-Sang Natinal University Hospital | Gyeongsang National Hospital | Gyeongsang National University Changwon Hospital | Gyeongsang National University Hospital | Gyeongsang National University Hospital IRB | Gyeongsang University Hospital | Gyeongsan National University Hospital
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2006Last known activity
Aug 26, 2022
Timeline
1940s
- Jan 1, 1948
Gyeongsang University— Founded
Drugs by trial phase (38 distinct, 31 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Arthritis
- Arthritis, Rheumatoid
- Biliary Tract Neoplasms
- Cancer Pain
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Coronary Artery Disease
- Coronary Disease
- Coronary Stenosis
- Coronavirus Infections
- Diabetes Mellitus
- Edema
- Erectile Dysfunction
- Essential Hypertension
- Heart Diseases
- Hiccup
- Hyperplasia
- Hypertension
- Infarction
- Lower Urinary Tract Symptoms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, T-Cell
- Macular Edema
- Myocardial Infarction
- Myocardial Ischemia
- Myocardial Reperfusion Injury
- Osteoarthritis
- Osteoarthritis, Knee
- Pancreatic Neoplasms
- Pneumonia
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Reperfusion Injury
- Severe Acute Respiratory Syndrome
- ST Elevation Myocardial Infarction
- Stroke
- Syndrome
- Ventricular Remodeling
Recent trials (50)
- NCT05523947OfficialPhase 1/Phase 2Aug 26, 2022
- NCT04418128Lead sponsorPhase 2/Phase 3May 25, 2020
- NCT04418128Reponsible party - principal investigatorPhase 2/Phase 3May 25, 2020
- NCT04418128Overall official - principal investigatorPhase 2/Phase 3May 25, 2020
- NCT04427930Overall official - principal investigatorPhase 3Apr 13, 2020
- NCT04734353Lead sponsorPhase 4Jan 15, 2020
- NCT04734353Overall official - principal investigatorPhase 4Jan 15, 2020
- NCT04014803CollaboratorPhase 4Jul 8, 2019
- NCT03990805Overall official - principal investigatorPhase 3Jun 11, 2019
- NCT04407312Lead sponsorPhase 4Jan 1, 2016
- NCT04407312Overall official - principal investigatorPhase 4Jan 1, 2016
- NCT04407312Reponsible party - principal investigatorPhase 4Jan 1, 2016
- NCT02780323Overall official - principal investigatorPhase 4Oct 1, 2015
- NCT02433795CollaboratorPhase 2May 1, 2015
- NCT02399657Overall official - principal investigatorPhase 4Feb 1, 2015
Details
- Founded
- Jinju, KR Jan 1, 1948
- Last known activity
- Aug 26, 2022